Balchem files Kappa bioscience financials: 2021 revenue NOK 241M, net profit NOK 14.6M

BALCHEM CORP

Kappa (Kechu Bidco) 2021: revenue NOK 240.9M, op. profit NOK 42.7M, net profit NOK 14.6M including NOK 26.7M discontinued ops loss.
Total assets NOK 1,059M, equity NOK 594M, borrowings NOK 245M, cash NOK 100M as of Dec 31, 2021.
Unaudited pro forma combined financials for FY2021 and H1 2022 also filed, reflecting acquisition.
Audit opinion qualified for omission of comparative info; prepared per IFRS for SEC Rule 3-05.
Discontinued ops loss of NOK 26.7M from Kappa Ingredients GmbH (deconsolidated Nov 2021).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.